Aspire Biopharma Holdings Inc (ASBP)

Apr 03, 2026

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Greenville Online

Apr 03, 2026

Apr 02, 2026

ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Fundamental Analysis & Valuation - ChartMill

Apr 02, 2026

Apr 01, 2026

ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill

Apr 01, 2026

Apr 01, 2026

Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 - patriotledger.com

Apr 01, 2026

Apr 01, 2026

Aspire Biopharma Provides Q3 2025 Business Update - columbiadailyherald.com

Apr 01, 2026

Mar 31, 2026

Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack) - Burlington Free Press

Mar 31, 2026

Mar 31, 2026

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - Record-Courier

Mar 31, 2026

Mar 31, 2026

Aspire Biopharma: Disruptive Sublingual Drug Delivery Technology, Pipeline, and Patent Portfolio Overview 798289 - Minichart

Mar 31, 2026

Mar 30, 2026

Aspire Biopharma 10-K: Revenue $6.2K, Net Loss $24.48M - TradingView

Mar 30, 2026

Mar 30, 2026

Reverse recap and sublingual pipeline reshape Aspire Biopharma (NASDAQ: ASBP) - Stock Titan

Mar 30, 2026

Mar 30, 2026

Aspire Biopharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener

Mar 30, 2026

Mar 26, 2026

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - patriotledger.com

Mar 26, 2026

Mar 25, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 25, 2026

Mar 25, 2026

ASBP Soars: Biotech Turbulence Fuels an Unexpected 17% Jump - bitget.com

Mar 25, 2026

Mar 24, 2026

Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director - ACCESS Newswire

Mar 24, 2026

Mar 20, 2026

Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion - Black Hills Pioneer

Mar 20, 2026

Mar 20, 2026

ASBP Technical Analysis | Trend, Signals & Chart Patterns | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill

Mar 20, 2026

Mar 19, 2026

Aspire Biopharma's Subsidiary Announces Retail Expansion Deal - National Today

Mar 19, 2026

Mar 18, 2026

Aspire Biopharma Plunges 19.5% on Intraday Freefall: What’s Fueling the Sharp Drop? - Bitget

Mar 18, 2026

Mar 18, 2026

Aspire subsidiary names John Choe as western sales director By Investing.com - Investing.com South Africa

Mar 18, 2026

Mar 17, 2026

Aspire subsidiary names John Choe as western sales director - Investing.com

Mar 17, 2026

Mar 17, 2026

He drove 70% sales growth at Yerbaé — now Buzz Bomb hires him - Stock Titan

Mar 17, 2026

Mar 17, 2026

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - The Gardner News

Mar 17, 2026

Mar 16, 2026

Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity - Erie Times-News

Mar 16, 2026

Mar 14, 2026

Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement - Democrat and Chronicle

Mar 14, 2026